DRKS00010774招募中不适用
Prostate Cancer Outcomes – Compare & Reduce Variation in Prostate Cancer Centers certified by the German Cancer Society; subproject MID-EPIC-D - PCO-D
Deutsche Krebsgesellschaft0 个研究点目标入组 70,000 人开始时间: 2016年9月8日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 70,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- one 至 one（—）
- 性别
- Male
入选标准
- •Patients with localized prostate cancer
排除标准
- •insufficient language skills to fill out questionnaire
研究者
相似试验
已完成
不适用
iving Well with Prostate Cancer: A randomised controlled trial of a mindfulness intervention for men with advanced prostate cancerAdvanced Prostate CancerPsychological Distress in men with advanced prostate cancerQuality of Life in men with advanced prostate cancerSupportive Care in men with advanced prostate cancerCancer - ProstatePublic Health - Health service researchACTRN12612000306819Cancer Council Queensland190
进行中（未招募）
1 期
A clinical study on 18F-PSMA-1007 PET/CT scans in patients with recurrent prostate cancer and in chronic prostate cancerMedDRA version: 21.1Level: LLTClassification code 10076506Term: Castration-resistant prostate cancerSystem Organ Class: 100000004864Metastatic Prostate CancerEUCTR2021-000184-78-DKOdense University Hospital50
已完成
3 期
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate CancerProstate CancerNCT01809691SWOG Cancer Research Network1,313
已完成
不适用
Prostate Cancer - Comparative Outcomes of New Conceptual Paradigms for TreatmentProstate CancerNCT04890314Weill Medical College of Cornell University1,953
招募中
不适用
Evaluation of the effects of surgicel in open prostatectomy surgeryIRCT20200219046557N1Tabriz University of Medical Sciences30